Literature DB >> 26968991

Propaganda or the cost of innovation? Challenging the high price of new drugs.

Narcyz Ghinea1, Wendy Lipworth2, Ian Kerridge2.   

Abstract

Mesh:

Year:  2016        PMID: 26968991     DOI: 10.1136/bmj.i1284

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  3 in total

1.  Access to High Cost Cancer Medicines Through the Lens of an Australian Senate Inquiry-Defining the "Goods" at Stake.

Authors:  Narcyz Ghinea; Miles Little; Wendy Lipworth
Journal:  J Bioeth Inq       Date:  2017-07-18       Impact factor: 1.352

2.  Orphan Drug Pricing and Costs: A Case Study of Kalydeco and Orkambi.

Authors:  Aidan Hollis
Journal:  Healthc Policy       Date:  2019-08

3.  Anticancer drug prices and clinical outcomes: a cross-sectional study in Italy.

Authors:  Francesco Trotta; Flavia Mayer; Francesco Barone-Adesi; Immacolata Esposito; Ranadhir Punreddy; Roberto Da Cas; Giuseppe Traversa; Francesco Perrone; Nello Martini; Bishal Gyawali; Antonio Addis
Journal:  BMJ Open       Date:  2019-12-10       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.